Search by Drug Name or NDC
NDC 46287-0055-01 Liqrev 10 mg/mL Details
Liqrev 10 mg/mL
Liqrev is a ORAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by CMP Pharma, Inc.. The primary component is SILDENAFIL CITRATE.
MedlinePlus Drug Summary
Sildenafil (Viagra) is used to treat erectile dysfunction (impotence; inability to get or keep an erection) in men. Sildenafil (Liqrev, Revatio) is used to improve the ability to exercise in adults (Liqrev, Revatio) and children 1 year of age and older (Revatio) with pulmonary arterial hypertension (PAH; high blood pressure in the vessels carrying blood to the lungs, causing shortness of breath, dizziness, and tiredness). Sildenafil is in a class of medications called phosphodiesterase (PDE) inhibitors. Sildenafil treats erectile dysfunction by increasing blood flow to the penis during sexual stimulation. This increased blood flow can cause an erection. Sildenafil treats PAH by relaxing the blood vessels in the lungs to allow blood to flow easily. If you are taking sildenafil to treat erectile dysfunction, you should know that it does not cure erectile dysfunction or increase sexual desire. Sildenafil does not prevent pregnancy or the spread of sexually transmitted diseases such as human immunodeficiency virus (HIV).
Related Packages: 46287-0055-01Last Updated: 04/14/2024
MedLinePlus Full Drug Details: Sildenafil
Product Information
| NDC | 46287-0055 |
|---|---|
| Product ID | 46287-055_fea042e2-5fee-4dad-8a1c-ff5930d2e55a |
| Associated GPIs | |
| GCN Sequence Number | 084720 |
| GCN Sequence Number Description | sildenafil citrate ORAL SUSP 10 MG/ML ORAL |
| HIC3 | B1D |
| HIC3 Description | PULM.ANTI-HTN,SEL.C-GMP PHOSPHODIESTERASE T5 INHIB |
| GCN | 54078 |
| HICL Sequence Number | 018084 |
| HICL Sequence Number Description | SILDENAFIL CITRATE |
| Brand/Generic | Brand |
| Proprietary Name | Liqrev |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | sildenafil |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SUSPENSION |
| Route | ORAL |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/mL |
| Substance Name | SILDENAFIL CITRATE |
| Labeler Name | CMP Pharma, Inc. |
| Pharmaceutical Class | Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA214952 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 46287-0055-01 (46287005501)
| NDC Package Code | 46287-055-01 |
|---|---|
| Billing NDC | 46287005501 |
| Package | 122 mL in 1 BOTTLE (46287-055-01) |
| Marketing Start Date | 2023-04-30 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |